Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2007
02/08/2007US20070032507 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug.
02/08/2007US20070032492 Cytokine Inhibitors
02/08/2007US20070032487 Inhibitors of phosphatidylinositol 3-kinase
02/08/2007US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
02/08/2007US20070032465 Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha
02/08/2007US20070032417 Peptides and therapeutic uses thereof
02/08/2007US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
02/08/2007US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents
02/08/2007US20070031441 Immunotherapy based on dendritic cells
02/08/2007US20070031421 Inhibitors targeting osteoclast-associated protein
02/08/2007US20070031415 Regulation of interaction between rapl and rap1
02/08/2007US20070031405 Use of A33 antigens and jam-it
02/08/2007US20070031375 IL-16 antagonist peptides and DNA encoding the peptides
02/08/2007US20070031368 Chemokine conjugates
02/08/2007DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use
02/08/2007CA2617213A1 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
02/08/2007CA2617150A1 Use of chk2 kinase inhibitors for cancer treatment
02/08/2007CA2615574A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/07/2007EP1749817A1 Neurogenic pain control agent composition
02/07/2007EP1749534A2 Use of parasitic biological agents for prevention and control of autoimmune diseases
02/07/2007EP1749524A2 Inflammation-inhibiting compounds
02/07/2007EP1749520A1 Water-dispersible encapsulated sterols
02/07/2007EP1749016A2 Adenosine receptor agonists
02/07/2007EP1749004A1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents
02/07/2007EP1748989A2 Aryl sulfonamides
02/07/2007EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity
02/07/2007EP1315501B1 Alpha v integrin receptor antagonists
02/07/2007EP1261336B1 Il-8 receptor antagonists
02/07/2007EP1242382B1 Tricyclic protein kinase inhibitors
02/07/2007EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
02/07/2007EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor
02/07/2007EP0602112B1 High content ibuprofen agglomerates and process to prepare them
02/07/2007CN2865689Y Medicated membrane or ointment for external use
02/07/2007CN1909929A Anti-inflammatory analgesic for external use
02/07/2007CN1909906A 2,6-disubstituted piperidines as modulators of chemokine receptor activity
02/07/2007CN1908014A Modified peptides as therapeutic agents
02/07/2007CN1907974A Huperzine with analgesic function and derivative thereof
02/07/2007CN1907480A Decoction preparation for treating rheumatoid arthritis and its preparation process
02/07/2007CN1907473A Fuming-washing medicine for treating arthritis with deficiency of yin of liver and kidney and its preparation
02/07/2007CN1907460A Externally used Chinese herbal medicinal composition
02/07/2007CN1907447A Outer applying medicine for treating scapulohumeral periarthritis and its preparation process
02/07/2007CN1907441A Decoction preparation for treating appendicitis and its preparation process
02/07/2007CN1907428A Medicinal composition for treating high fever and preparation method thereof
02/07/2007CN1907423A Oral administration preparation such as inflammation-fever removal tablet et al. and preparation method thereof
02/07/2007CN1907410A Chinese traditional medicine preparation for treating bone fracture and traumatic injury
02/07/2007CN1907409A Medicament for treating acute soft tissue injury and its preparation process
02/07/2007CN1907403A Fuming-washing treating medicine for treating exogenous fever and its preparation
02/07/2007CN1907352A Outer applying medicine for treating scapulohumeral periarthritis and its preparation process
02/07/2007CN1907350A Composition, extract thereof and its pharmaceutical use
02/07/2007CN1907349A Fuming-washing medicine for treating Yuxuebi capsule arthritis and its preparation
02/07/2007CN1907329A Children's rheum tablet and its preparation
02/07/2007CN1907317A Medicine for treating impotence, spermatorrhea and chronic renal failure, and its preparing process
02/07/2007CN1907314A Use of dandelion phenolic acid effective kind part for inhibiting gynaecologic mammitis
02/07/2007CN1907292A Emulsion of baicalin for injection and its preparation process
02/07/2007CN1907291A Injectio for nanometer notoginsenoside and its preparing method
02/07/2007CN1907282A Injection for treating arthralgia due to wind-cold-dampness disease and its preparation process
02/07/2007CN1298720C Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method
02/07/2007CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions
02/07/2007CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof
02/07/2007CN1298703C Cyanopyrolidine derivatives
02/07/2007CN1298373C Chinese medicine for treating hypertension
02/07/2007CN1298365C Granule of ingangteng for treating inflammatory gynecopathy and its preparation method
02/07/2007CN1298350C Medicinal spirit for rheumatic arthritis
02/07/2007CN1298326C Transdermal patch for external use comprising fentanyl
02/07/2007CN1298325C Stabilized oil-in-water emulsion of matrine alkaloid for venous purpose and production thereof
02/07/2007CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors
02/07/2007CN1298323C Fused pyrrolocarbazoles against inflammation
02/07/2007CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II
02/06/2007US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid
02/06/2007US7173061 For diagnosis or in vivo imaging of Amyloid-associated diseases such as diabetes; radiolabelled
02/06/2007US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands
02/06/2007US7173038 Treatment of diseases such as cancer or arthritis
02/06/2007US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007US7173018 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches
02/06/2007US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
02/06/2007US7172763 Post-operative pain treatment by peripheral administration of a neurotoxin
02/06/2007US7172752 Synergistic mixture of antiserotonine agents and glucocorticoids; inhalation
02/06/2007US7172750 Compositions and methods for the treatment and diagnosis of immune disorders
02/06/2007CA2362816C Valdecoxib compositions
02/06/2007CA2274103C Methods of treating mental diseases, inflammation and pain
02/06/2007CA2258662C Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
02/01/2007WO2007013964A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors
02/01/2007WO2007013824A1 Biologically active extracts from stephania brachyandra
02/01/2007WO2007013290A1 Anti-inflammatory analgesic agent
02/01/2007WO2007012464A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
02/01/2007WO2006122156A3 Compounds for modulating trpv3 function
02/01/2007WO2004084822A3 Methods for inducing immune tolerance
02/01/2007US20070027196 Activator of peroxisome proliferator-activated receptor delta
02/01/2007US20070027174 Phenylalanine Enamide Derivatives
02/01/2007US20070027149 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors
02/01/2007US20070027144 Novel use of cannabinoid receptor agonist
02/01/2007US20070027131 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
02/01/2007US20070027086 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as antiinflammatory and immunomodulatory agent; inhibit the production of nitric oxide (NO)
02/01/2007US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof
02/01/2007US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease
02/01/2007US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
02/01/2007US20070025991 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
02/01/2007US20070025990 Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
02/01/2007US20070025989 Administration of agents for the treatment of inflammation